Bevacizumab in Ovarian Cancer: State of the Art and Unanswered Questions

This study focuses on the results of pivotal trials, emerging data, ongoing research, and still unanswered questions about the most adequate dosage of bevacizumab and its potential activity after disease progression or rechallenge in previously treated patients.Chemotherapy 2017;62:111-120
Source: Chemotherapy - Category: Cancer & Oncology Source Type: research